Yahoo - what a remarkable buying opportunity!
How often can you buy into a company with such certainty you're getting a bargain.
Neuren was undervalued in the past, but it also had no revenues and binary drug approval risk - so you were playing the odds.
That's all changed. Neuren is now a blue chip cash cow with a bucketload of cash in the bank and guaranteed profits (let me repeat that - guaranteed profits) for the medium term future. Oh, AND huge upside potential.
On fundamentals Neuren is arguably now one of the lowest risk shares on the ASX .
I'm buying more and expect to double my money in ~6 months with little risk.
Perhaps I've drunk too much koolade. But I'm mystified how - as the base case for Neuren is now based on facts and certainty (Daybue IS approved, it IS the only drug for Retts, it IS working for patients, it IS generating rapidly ramping revenues, there IS $250 million in Neuren's bank account).
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-7503
-
- There are more pages in this discussion • 4,364 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.83 |
Change
0.220(1.62%) |
Mkt cap ! $1.784B |
Open | High | Low | Value | Volume |
$13.60 | $14.00 | $13.51 | $2.824M | 204.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 137 | $13.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.83 | 666 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 87 | 13.820 |
13 | 915 | 13.810 |
8 | 1101 | 13.800 |
5 | 700 | 13.790 |
5 | 1076 | 13.780 |
Price($) | Vol. | No. |
---|---|---|
13.830 | 666 | 12 |
13.840 | 1060 | 8 |
13.850 | 557 | 4 |
13.860 | 511 | 3 |
13.870 | 684 | 4 |
Last trade - 15.20pm 13/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online